Enforcement record
注意喚起 disclosure naming OxyElite Pro
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
注意喚起
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
25 December 2013
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Completed archive verified
- Captured: Jul 12, 2026, 03:42 PM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Available sources and saved files are listed in the public documents section below.
Action summary
- Company
- OxyElite ProJapanese onlyOriginal: OxyElite Pro
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- 注意喚起注意喚起
- Action date
- 25 December 2013
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- サプリメント
Violation
The product was obtained through personal importation, and there is no record of OxyElite Pro being imported as a commercial activity in Japan. However, due to the potential for health damage from personal use, a warning notice was again disseminated to prefectural authorities and others as detailed in the attached document.
Show original Japanese text
個人輸入を介して入手したものであり、日本における OxyElite Ｐｒｏ の業としての輸入実績はありませんが、今後も個人使用による健康被害の可能性（注）もあることから、再度、別添のとおり各都道府県等に対し注意喚起について周知を行いました。
Public documents and saved materials
View official publications and the available saved materials. Purchase a one-time evidence pack to download the compiled files.
Loading materials…
Compliance context
Context neededThis is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.